Method of inhibiting snoring and obstructive sleep apnea

Details Method of inhibiting snoring and obstructive sleep apnea Method of inhibiting snoring and obstructive sleep apnea

1984-04-26

1985-11-05

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514561, 514648, A61K 3144, A61K 31135, A61K 31195

Patent

active

045514739

ABSTRACT:
Snoring and obstructive sleep apnea are relieved in most instances by administering an effective dose of a muscle relaxant that acts at the spinal or supra-spinal level. A presently preferred drug is orphenadrine citrate.

REFERENCES:
patent: 2991225 (1961-07-01), Harms
Goth, Medical Pharmacology, 1981, pp. 171 et seq.
Goodman and Gilman's, The Pharmacological Basis of Therapeutics, Sixth Edition, pp. 488 et seq.
J. B. Lippincott Company's, Facts and Comparisons, (A Loose-Leaf Drug Information Service, pp. 285-289a).
Edwin Kiester, Jr., 50 Plus, A Little Night Music, Feb. 1984, pp. 68-69.
Cardiovascular News, Surgery Foils Obstructive Sleep Apnea, Mar. 1984.
David N. F. Fairbanks, MD, Hospital Medicine, Snoring: Not Funny--Not Hopeless, Mar. 1984, pp. 173-184.

Affiliated with

Also associated with

Rating

Method of inhibiting snoring and obstructive sleep apnea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting snoring and obstructive sleep apnea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting snoring and obstructive sleep apnea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-296162